Velcadito: Low dose of bortezomib with melphalan and prednisone for ≥75‐year‐olds newly diagnosed with multiple myeloma.

Autor: Pérez‐Persona, Ernesto1,2 (AUTHOR) Ernestoprez@gmail.com, Oiartzabal‐Ormategui, Itziar3 (AUTHOR), Herraez, Susana4 (AUTHOR), Menchaca, Carmen2 (AUTHOR), Cuevas‐Palomares, Laida2 (AUTHOR), Santamaría‐López, Ana2 (AUTHOR), Díez‐Angulo, Rosana2 (AUTHOR), Robles‐Castro, Diego2 (AUTHOR), de Miguel‐Sánchez, Carlos2 (AUTHOR), Gabilondo‐Jalón, Miren2 (AUTHOR), Pisón‐Herrero, Carlos2 (AUTHOR), Unamunzaga‐Cilaurren, Ariane2 (AUTHOR), Vega González‐Viñaspre, Ana2 (AUTHOR), Salcedo‐Cuesta, Laura2 (AUTHOR), Mendizabal‐Abad, Arantza4 (AUTHOR), Guinea de Castro, José María2 (AUTHOR)
Zdroj: European Journal of Haematology. Jun2022, Vol. 108 Issue 6, p532-535. 4p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje